South Korea
· Delayed Price · Currency is KRW HLB bioStep Co.,Ltd. Statistics
Total Valuation
HLB bioStep Co.,Ltd. has a market cap or net worth of KRW 197.44 billion. The enterprise value is 196.72 billion.
| Market Cap | 197.44B |
| Enterprise Value | 196.72B |
Important Dates
The last earnings date was Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HLB bioStep Co.,Ltd. has 84.20 million shares outstanding. The number of shares has increased by 7.10% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 84.20M |
| Shares Change (YoY) | +7.10% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | 4.61% |
| Float | 65.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| PB Ratio | 1.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.00 |
| EV / Sales | 4.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.36 |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.30.
| Current Ratio | 1.15 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.24 |
| Interest Coverage | -3.81 |
Financial Efficiency
Return on equity (ROE) is -5.76% and return on invested capital (ROIC) is -2.84%.
| Return on Equity (ROE) | -5.76% |
| Return on Assets (ROA) | -2.65% |
| Return on Capital (ROIC) | -2.84% |
| Revenue Per Employee | 325.60M |
| Profits Per Employee | -40.71M |
| Employee Count | 151 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 11.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -19.45% |
| 50-Day Moving Average | 2,250.36 |
| 200-Day Moving Average | 2,935.49 |
| Relative Strength Index (RSI) | 41.81 |
| Average Volume (20 Days) | 216,973 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HLB bioStep Co.,Ltd. had revenue of KRW 49.17 billion and -6.15 billion in losses. Loss per share was -78.55.
| Revenue | 49.17B |
| Gross Profit | 32.90B |
| Operating Income | -7.30B |
| Pretax Income | -5.96B |
| Net Income | -6.15B |
| EBITDA | -3.31B |
| EBIT | -7.30B |
| Loss Per Share | -78.55 |
Balance Sheet
The company has 40.40 billion in cash and 35.61 billion in debt, giving a net cash position of 4.79 billion or 56.93 per share.
| Cash & Cash Equivalents | 40.40B |
| Total Debt | 35.61B |
| Net Cash | 4.79B |
| Net Cash Per Share | 56.93 |
| Equity (Book Value) | 119.25B |
| Book Value Per Share | 1,367.87 |
| Working Capital | 7.10B |
Cash Flow
In the last 12 months, operating cash flow was -3.23 billion and capital expenditures -12.69 billion, giving a free cash flow of -15.92 billion.
| Operating Cash Flow | -3.23B |
| Capital Expenditures | -12.69B |
| Free Cash Flow | -15.92B |
| FCF Per Share | -189.04 |
Margins
Gross margin is 66.92%, with operating and profit margins of -14.85% and -12.50%.
| Gross Margin | 66.92% |
| Operating Margin | -14.85% |
| Pretax Margin | -12.12% |
| Profit Margin | -12.50% |
| EBITDA Margin | -6.73% |
| EBIT Margin | -14.85% |
| FCF Margin | -32.37% |
Dividends & Yields
HLB bioStep Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.10% |
| Shareholder Yield | -7.10% |
| Earnings Yield | -3.35% |
| FCF Yield | -8.06% |
Stock Splits
The last stock split was on May 31, 2022. It was a forward split with a ratio of 9.
| Last Split Date | May 31, 2022 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
HLB bioStep Co.,Ltd. has an Altman Z-Score of 3.38.
| Altman Z-Score | 3.38 |
| Piotroski F-Score | n/a |